Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Receivables (2016 - 2026)

Biomerica's Change in Receivables history spans 17 years, with the latest figure at -$64000.0 for Q1 2026.

  • Quarterly results put Change in Receivables at -$64000.0 for Q1 2026, down 6.67% from a year ago — trailing twelve months through Feb 2026 was -$315000.0 (down 325.0% YoY), and the annual figure for FY2025 was -$209000.0, down 197.21%.
  • Change in Receivables for Q1 2026 was -$64000.0 at Biomerica, up from -$227000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $708000.0 in Q3 2023 to a low of -$536000.0 in Q2 2025.
  • The 5-year median for Change in Receivables is $26015.0 (2022), against an average of $79850.0.
  • Peak annual rise in Change in Receivables hit 1687.43% in 2023, while the deepest fall reached 749.12% in 2023.
  • Year by year, Change in Receivables stood at $57000.0 in 2022, then crashed by 749.12% to -$370000.0 in 2023, then skyrocketed by 38.11% to -$229000.0 in 2024, then increased by 0.87% to -$227000.0 in 2025, then skyrocketed by 71.81% to -$64000.0 in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$64000.0, -$227000.0, and $512000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.